Rare diseases
Investigational molecules
Locations
Study on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment
The NetherlandsStudy on the Effect of Adding Leuprorelin Acetate to Radiotherapy for Patients with Oligo-recurrent Prostate Cancer with Up to 4 Metastases
The NetherlandsStudy of Irinotecan with FOLFOX and Bevacizumab for Patients with Unresectable Colorectal Cancer Metastases
The NetherlandsStudy of reduced pembrolizumab dosing compared to standard dose in patients with advanced non-small cell lung cancer
The NetherlandsStudy Comparing Rituximab with Drug Combination for Patients with Newly Diagnosed High-Risk Burkitt Lymphoma
The NetherlandsStudy on Alpelisib and Fulvestrant for Advanced Breast Cancer in Patients with PIK3CA Mutation and Hormone-Receptor Positive, HER2 Negative Tumors
The NetherlandsStudy on Venetoclax, Ibrutinib, and Obinutuzumab for Chronic Lymphocytic Leukemia Patients Not in Complete Remission or with Detectable Bone Marrow Disease
The NetherlandsStudy on Early Discontinuation of Nivolumab and Ipilimumab in Patients with Advanced Melanoma
The NetherlandsStudy on Vedolizumab for Patients with Active Ulcerative Colitis
The NetherlandsStudy on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough
The NetherlandsStudy of dose reduction strategy for tyrosine kinase inhibitors (imatinib, ponatinib, bosutinib, nilotinib, dasatinib) in patients with chronic myeloid leukemia
The NetherlandsStudy of Nivolumab for Patients with Esophageal Cancer Undergoing Active Surveillance After Chemoradiation
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
